SECUKINUMAB EFFICACY IN PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT ENTHESITIS AT BASELINE - POOLED ANALYSIS FROM TWO PHASE-III TRIALS OVER 2 YEARS
Wallman JK, Schett G, Mcinnes IB, Quebe-Fehling E, Rasouliyan L, Pricop L, Fasth AE, Gaillez C (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 36
Pages Range: 728-728
Journal Issue: 4
Authors with CRIS profile
Involved external institutions
Novartis AG
Switzerland (CH)
Novartis Sverige AB
Sweden (SE)
RTI Health Solutions
United States (USA) (US)
University of Glasgow
United Kingdom (GB)
Lund University / Lunds universitet
Sweden (SE)
Switzerland (CH)
Novartis Sverige AB
Sweden (SE)
RTI Health Solutions
United States (USA) (US)
University of Glasgow
United Kingdom (GB)
Lund University / Lunds universitet
Sweden (SE)
How to cite
APA:
Wallman, J.K., Schett, G., Mcinnes, I.B., Quebe-Fehling, E., Rasouliyan, L., Pricop, L.,... Gaillez, C. (2018). SECUKINUMAB EFFICACY IN PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT ENTHESITIS AT BASELINE - POOLED ANALYSIS FROM TWO PHASE-III TRIALS OVER 2 YEARS. (pp. 728-728).
MLA:
Wallman, J. K., et al. "SECUKINUMAB EFFICACY IN PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT ENTHESITIS AT BASELINE - POOLED ANALYSIS FROM TWO PHASE-III TRIALS OVER 2 YEARS." 2018. 728-728.
BibTeX: Download